Startup investing is often likened to betting on a racehorse, but the wisdom of whether to back the “horse” (the business model and industry) or the “jockey” (the founding team) continues to polarize venture capitalists, angel investors, and institutional financiers alike. The analogy is simple but powerful: Do you place your money on a market-leading…

IBM, one of the oldest and most celebrated players in the enterprise technology space, is actively grappling with an urgent and complex challenge: how to align large language models (LLMs) effectively with corporate and industrial needs. As enterprise clients experiment across the AI spectrum—from open-source models like Meta’s Llama series to closed, commercial favorites such…

The recent decision in which Anthropic, the AI startup behind Claude, was found not to have infringed copyright through the ingestion of published works into its large language models (LLMs), has reignited critical debates on the existing regulatory vacuum in AI development. As reported by Bloomberg Opinion on June 26, 2025, the ruling essentially declared…

In today’s ever-connected world, sleep has emerged as a lucrative investment frontier—paradoxical though it may seem. As mental and physical health take center stage in post-pandemic work-life recalibrations, investors remain conspicuously bullish on sleep-focused startups. Whether it’s through smart wearable devices, digital therapeutics, or AI-backed diagnostics, these companies are attracting sustained venture capital interest even…

The explosive integration of AI agents into modern workplaces is reshaping not only operational workflows but also the security architecture that underpins digital organizations. As we move deeper into 2025, traditional Identity and Access Management (IAM) solutions are being stretched thin. This shift demands a rethinking of how digital identities are managed—not just for humans,…

In a groundbreaking development at the intersection of artificial intelligence and genomics, DeepMind’s latest innovation, AlphaGenome, is redefining our understanding of the human genome. Officially unveiled in May 2024 and gaining momentum in early 2025, AlphaGenome is poised to radically improve genomic annotation and interpretation—an area plagued by decades of complexity and ambiguity. With its…